Associate Professor Denese C. Marks

Associate Professor Denese C Marks

A/Prof Denese C. Marks

Research Program Leader

Associate Professor, School of Medicine, The University of Sydney


Connect with A/Prof Marks Email Research Gate Pubmed

Denese leads the Product Development team and has over 25 years’ research experience. She holds an adjunct appointment with the School of Medicine, University of Sydney.  Her research focuses on improving blood component processing and storage, including donor attributes that may influence blood component quality, and clinical trials of new blood products.

She has over 90 peer-reviewed publications and holds international  leadership roles with the Biomedical Excellence for Safer Transfusion (BEST) Collaborative, and the International Society of Blood Transfusion.

Awards
  • Australian and New Zealand Society of Blood Transfusion (ANZSBT) grant
  • Chief Investigator on two NHMRC-funded clinical trial grants
  • Chief Investigator on an Australian Research Council grant
  • Chief investigator on a Medical Research Future Fund grant
Leadership
  • Executive committee of ISBT Cellular Therapies Working Party
  • Vox Sanguinis section editor for Blood Component Collection and Processing
  • Regional Director, The ISBT Board of Regional Directors, Western Pacific Region
  • Full scientific Member of the BEST Collaborative Conventional Components Team
  • Reviewer for journals including Transfusion, Vox Sanguinis, Platelets, Journal of Transfusion and Apheresis Science, and Journal of Proteomics
  • Abstract reviewer for ISBT and AABB conference submissions

Key publications

A randomized, controlled pilot clinical trial of cryopreserved platelets for perioperative surgical bleeding: the CLIP-I trial (Editorial, p. 2759)
Reade MC, Marks DC, Bellomo R, Deans R, Faulke DJ, Fraser JF, Gattas DJ, Holley AD, Irving DO, Johnson L, Pearse BL, Royse AG, Wong J
2019
Transfusion
59:2794-2804.
An 8-week course of 45 mg of carbonyl iron daily reduces iron deficiency in female whole blood donors aged 18 to 45 years: results of a prospective randomized controlled trial
Marks DC, Speedy J, Robinson KL, Brama T, Capper HR, Mondy P, Keller AJ
2014
Transfusion
54:780-788.
Cryopreserved platelets: are we there yet?
Marks DC
2018
Transfusion
58:2092-2094.
The hemostatic activity of cryopreserved platelets is mediated by phosphatidylserine-expressing platelets and platelet microparticles
Johnson L, Coorey CP, Marks DC
2014
Transfusion
54:1917-1926.
A platelet-derived hydrogel improves neovascularisation in full thickness wounds.
Rahman MM, Garcia N, Loh YS, Marks DC, Banakh I, Jagadeesan P, Cameron NR, Yung-Chih C, Costa M, Peter K, Cleland H, Akbarzadeh S.
2021
Acta Biomaterialia
136:199-209

* This research was completed prior to starting with Lifeblood

Need help?